Indole‐3‐lactic acid ameliorates thrombocytopenia in primary immune thrombocytopenia by modulating the differentiation of Th17 and Tregs
British Journal of Haematology · 11.11.2026
DOI: 10.1111/bjh.70947 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 11.11.2026. Verfasst von Yanxia Zhan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China. Die Arbeit nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Medical Discipline Construction Project of the Xuhui District, Shanghai Municipal Committee of Science and Technology.
Abstract (Originalsprache)
Although some patients with primary immune thrombocytopenia (ITP) benefit from current treatments, there are still some refractory patients. Our previous research showed that the imbalance of the intestinal microbiota is associated with ITP. Indole‐3‐lactic acid (ILA) may act as a communication channel between the gut microbiota and the immune system. This study aimed to assess the ILA metabolism and the role in ITP. Plasma metabolites were measured by liquid chromatography–tandem mass spectrometry. Flow cytometry was used to analyse T‐cell subsets and Fc gamma receptors on macrophages. Cytokine mRNA expression and plasma levels were detected by real‐time quantitative polymerase chain reaction (qPCR) and a multiplex assay kit. An ITP mouse model was used to explore the effect of ILA on immune homeostasis. Newly diagnosed and refractory ITP patients with a deficiency of ILA and an imbalance of T helper cell type 17 (Th17)/regulatory T cells (Tregs). ILA alleviated thrombocytopenia in ITP mice by inhibiting Th17 differentiation and the expression of interleukin (IL)‐1β, tumour necrosis factor‐α (TNF‐α), interferon‐γ (IFN‐γ) and IL‐12/IL‐23p40, and by promoting Tregs differentiation. ILA reduced Th17 cells, increased the Treg/Th17 ratio, downregulated IL17A and TNFα mRNA, and upregulated IL10 mRNA in refractory ITP patients. ILA ameliorates thrombocytopenia in ITP by modulating Th17/Tregs differentiation and suppressing TNF‐α expression. Targeting ILA metabolism could be a promising therapeutic strategy for ITP.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
- Institute of Clinical Science, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Thoracic Surgery, Zhongshan-Xuhui Hospital, Fudan University, Shanghai, China.
- Center for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, China.
- Department of Hematology, Zhongshan Hospital Qingpu Branch, Fudan University, Shanghai, China.
ORCID-Profile: Yanxia Zhan, Pu Chen, Lili Ji, Dongmei Luo, Yunan Ling, Hao Chen, Yunfeng Cheng
Förderung
- National Natural Science Foundation of China
- Key Medical Discipline Construction Project of the Xuhui District
- Shanghai Municipal Committee of Science and Technology
- Shanghai Academic/Technology Researcher Leader Program
- Shanghai Engineering Research Center for Tumor Multitarget Gene Diagnosis
Zitieren
APA
Zhan, Y., Chen, P., Ji, L., Pang, H., Luo, D., Xu, P., Ling, Y., Cheng, L., Chen, H., & Cheng, Y. (2026). Indole‐3‐lactic acid ameliorates thrombocytopenia in primary immune thrombocytopenia by modulating the differentiation of Th17 and Tregs. British Journal of Haematology. https://doi.org/10.1111/bjh.70947
Vancouver
Zhan Y, Chen P, Ji L, Pang H, Luo D, Xu P, et al. Indole‐3‐lactic acid ameliorates thrombocytopenia in primary immune thrombocytopenia by modulating the differentiation of Th17 and Tregs. British Journal of Haematology. 2026. doi:10.1111/bjh.70947
BibTeX
@article{Zhan2026,
author = {Zhan, Yanxia and Chen, Pu and Ji, Lili and Pang, Hao and Luo, Dongmei and Xu, Pengcheng and Ling, Yunan and Cheng, Luya and Chen, Hao and Cheng, Yunfeng},
title = {Indole‐3‐lactic acid ameliorates thrombocytopenia in primary immune thrombocytopenia by modulating the differentiation of Th17 and Tregs},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70947}
}
EUVIMED